ANN ARBOR, MI (May 4, 2026) – Arboretum Ventures, a leading healthcare venture capital firm based in Ann Arbor, Michigan, today announced that Jeff Terrell has been promoted to Managing Partner.
Jeff joined Arboretum in 2025 as an Investment Partner, bringing more than a decade of venture investing experience from Hatteras Venture Partners where he co-led the firm’s medical device practice. Since joining Arboretum, Jeff has played a key role in sourcing and executing new investments, including the firm’s recent Fund VI investment into Pharaoh Neuroscience, a company developing a novel cerebrospinal fluid (CSF) management platform to improve outcomes following neurological injury.
“Jeff brings deep sector expertise, a strong network across our medtech ecosystem and a collaborative and highly constructive approach to company building,” said Dan Kidle, Managing Partner. “He has quickly become a key contributor to our investment efforts, and we are excited for him to play a more integral role in leading and shaping the firm’s investment strategy as we continue to build and support transformative healthcare companies.”
Jeff’s investment experience spans medical devices, diagnostics, and tech-enabled services, working closely with management teams from early-stage development through commercialization and exit. He currently serves as board chairman at AtaCor Medical and is a director at Boomerang Medical and Pharaoh Neuroscience. During his tenure at Hatteras, Jeff invested alongside Arboretum in Dropworks, which was acquired by Bio-Rad Laboratories and served on the boards of Cardiosense, 410 Medical, and Endogenex. Jeff was also a board observer at Contego Medical, Rapid Pulse, and Bivarus (acquired by Press Ganey).
“I am honored to step into this role and continue investing in great companies alongside such a strong and collaborative team,” said Terrell. “Arboretum has a long history of backing impactful healthcare companies, and I look forward to helping drive the next phase of growth for the firm.”
Jeff began his career at Medtronic as a clinical specialist and sales representative focused on spinal implants and image-guided surgery equipment for neurosurgery. Prior to launching his career at Medtronic, he spent two years pursuing a childhood dream to become an NFL quarterback, enjoying short stints with the Kansas City Chiefs and Dallas Cowboys. Jeff earned his undergraduate degree from Princeton University and an MBA from Duke University’s Fuqua School of Business.
About Arboretum Ventures:
Arboretum Ventures is a venture capital firm specializing in the healthcare sector. Founded in 2002, the firm has raised $1 billion in capital across its funds with its most recent Fund VI closing in 2023 at $268 million. Arboretum focuses on capital‐efficient investment opportunities in medical devices, life science tools & diagnostics, tech‐enabled care delivery, and pharma adjacencies. Arboretum’s guiding vision is to identify transformative healthcare companies developing novel solutions to significant healthcare issues that simultaneously reduce cost and improve outcomes. For information, visit www.arboretumvc.com.